Previous works indicated that the genetic reduction of TTR in an AD mouse model results in increased Aβ brain levels9, 10; another work using 7 month old female mice also showed increased Aβ1-42 plasma levels in AD/TTR+/− mice as compared to age-and gender-matched AD/TTR+/+ animals. This evidence concerns the gene TTR and Alzheimer disease.